PEctin Rapid Fentanyl Efficacy Clinical Trial For pAin at Swallowing Undergoing radioTherapy
Status:
Withdrawn
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The primary objective of the present phase IIIb study is to assess the efficacy of FPNS
compared with Physician Choice-Usual Care (PC-UC) in the reduction of swallowing predictable
BTP in head and neck cancer patients undergoing radiotherapy with or without chemotherapy.
Phase:
Phase 3
Details
Lead Sponsor:
L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.